COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02472145
Brief Title: An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

First Submitted : April 29, 2015
First Submitted that Met QC Criteria : June 10, 2015
First Posted : June 15, 2015 (Estimate)

Results First Submitted : January 24, 2019
Results First Submitted that Met QC Criteria : February 27, 2019
Results First Posted : February 28, 2019

Last Update Submitted that Met QC Criteria : March 11, 2019
Last Update Posted : March 19, 2019